Millendo Therapeutics Provides Corporate and Pipeline Update 06/23/2020Millendo Therapeutics Reports First Quarter 2020 Operating and Financial Results 05/08/2020Millendo Therapeutics Announces Topline Results for Pivotal Phase 2b Study of Livoletide in Patients with Prader-Willi Syndrome (PWS) 04/06/2020